Farmaceutici Procemsa Spa
Farmaceutici Procemsa Spa, commonly referred to as Procemsa, is a prominent player in the pharmaceutical industry, headquartered in Italy. Established in 1976, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, particularly in the areas of injectables and sterile solutions. With a strong operational presence across Europe and beyond, Procemsa is renowned for its commitment to innovation and quality assurance. The company’s core offerings include a diverse range of injectable medications and advanced pharmaceutical formulations, distinguished by their rigorous adherence to safety and efficacy standards. Procemsa has achieved notable recognition within the industry, positioning itself as a trusted partner for healthcare providers. Its dedication to research and development continues to drive its success, ensuring that it remains at the forefront of pharmaceutical advancements.
DitchCarbon Score
How does Farmaceutici Procemsa Spa's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Farmaceutici Procemsa Spa's score of 10 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Farmaceutici Procemsa Spa's reported carbon emissions
In 2022, Farmaceutici Procemsa Spa reported total greenhouse gas emissions of approximately 2,928,267,000 kg CO2e. This figure includes Scope 1 emissions of about 1,802,600 kg CO2e, Scope 2 emissions (market-based) of approximately 1,696,500 kg CO2e, and Scope 3 emissions of around 25,783,570 kg CO2e. The company has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 23% by 2030, using 2021 as the base year. This target has been approved through the Science Based Targets initiative (SBTi) and aligns with the goal of limiting global warming to well below 2°C. Additionally, Farmaceutici Procemsa Spa is committed to measuring and reducing its Scope 3 emissions, which represent a significant portion of its overall carbon footprint. These initiatives reflect the company's dedication to sustainability and its proactive approach to addressing climate change within the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 2,307,100 | 0,000,000 | 0,000,000 |
| Scope 2 | 1,211,600 | 0,000,000 | 0,000,000 |
| Scope 3 | 6,701,100 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Farmaceutici Procemsa Spa is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
